Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity and Share-Based Compensation

v3.21.2
Stockholders' Equity and Share-Based Compensation
9 Months Ended
Oct. 02, 2021
Stockholders' Equity and Share-Based Compensation  
Stockholders' Equity and Share-Based Compensation

Note 3 – Stockholders’ Equity and Share-Based Compensation

Options and Restricted Stock Units

The Company had the following common stock option activity during the thirty-nine weeks ended October 2, 2021:

Granted options to purchase 0 common shares.
Exercise of 1,701 options to purchase common shares.
Forfeiture of 58 options to purchase common shares.
Expiration of 3 options to purchase common shares.

The following table summarizes the Company’s restricted stock unit ("RSU") activity for the thirty-nine weeks ended October 2, 2021, and details regarding the awards outstanding and exercisable as of October 2, 2021 (in thousands):

Weighted Average

Weighted

Remaining

Average

Contractual

Aggregate

    

Shares

    

Exercise Price

    

Term (in years)

    

Intrinsic Value

Vested and expected to vest as of January 2, 2021

3,143

 

$

Awarded

2,568

 

$

Vested

(2,588)

 

$

Forfeited

(22)

 

$

Awards outstanding, October 2, 2021

3,101

 

$

10.65

 

$

49,061

Vested and expected to vest as of October 2, 2021

3,101

 

$

10.65

 

$

49,061

During the thirty-nine weeks ended October 2, 2021, 63 RSUs that vested were time-based and 2,525 were performance-based.

For the thirteen and thirty-nine weeks ended October 2, 2021, we recorded compensation costs related to stock options and RSUs of $4,597 and $12,887, respectively, of which $233 and $622, respectively, related to common shares issued to consultants as part of their compensation for services provided during the periods. For the thirteen and thirty-nine weeks ended September 26, 2020, we recorded compensation costs related to stock options and RSUs of $1,773 and $6,466, respectively. As of October 2, 2021, there was unrecognized compensation expense related to stock options and RSUs of $26,318 that will be expensed through September 2025.